Your browser doesn't support javascript.
loading
T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome.
Kumar, Deepak; Prince, Chengyu; Bennett, Carolyn M; Briones, Michael; Lucas, Laura; Russell, Athena; Patel, Kiran; Chonat, Satheesh; Graciaa, Sara; Edington, Holly; White, Michael H; Kobrynski, Lisa; Abdalgani, Manar; Parikh, Suhag; Chandra, Sharat; Bleesing, Jack; Marsh, Rebecca; Park, Sunita; Waller, Edmund K; Prahalad, Sampath; Chandrakasan, Shanmuganathan.
Afiliação
  • Kumar D; Aflac Cancer and Blood Disorder Center, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.
  • Prince C; Aflac Cancer and Blood Disorder Center, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.
  • Bennett CM; Aflac Cancer and Blood Disorder Center, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.
  • Briones M; Aflac Cancer and Blood Disorder Center, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.
  • Lucas L; Aflac Cancer and Blood Disorder Center, Children's Healthcare of Atlanta, Atlanta; GA.
  • Russell A; Genetics and Molecular Biology Graduate Program, Laney Graduate School, Emory University, Atlanta, GA.
  • Patel K; Allergy/Immunology Section, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.
  • Chonat S; Aflac Cancer and Blood Disorder Center, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.
  • Graciaa S; Aflac Cancer and Blood Disorder Center, Children's Healthcare of Atlanta, Atlanta; GA.
  • Edington H; Aflac Cancer and Blood Disorder Center, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.
  • White MH; Aflac Cancer and Blood Disorder Center, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.
  • Kobrynski L; Allergy/Immunology Section, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.
  • Abdalgani M; Children's Minnesota, Minneapolis, MN.
  • Parikh S; Aflac Cancer and Blood Disorder Center, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.
  • Chandra S; Division of Bone Marrow Transplantation and Immune Deficiency, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
  • Bleesing J; Division of Bone Marrow Transplantation and Immune Deficiency, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
  • Marsh R; Division of Bone Marrow Transplantation and Immune Deficiency, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
  • Park S; Department of Pathology, Children's Healthcare of Atlanta, Atlanta, GA.
  • Waller EK; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA; and.
  • Prahalad S; Division of Pediatric Rheumatology, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.
  • Chandrakasan S; Aflac Cancer and Blood Disorder Center, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.
Blood ; 139(3): 369-383, 2022 01 20.
Article em En | MEDLINE | ID: mdl-34424963
ABSTRACT
Pediatric Evans syndrome (pES) is increasingly identified as the presenting manifestation of several inborn errors of immunity. Despite an improved understanding of genetic defects in pES, the underlying immunobiology of pES is poorly defined, and characteristic diagnostic immune parameters are lacking. We describe the immune characteristics of 24 patients with pES and compared them with 22 patients with chronic immune thrombocytopenia (cITP) and 24 healthy controls (HCs). Compared with patients with cITP and HC, patients with pES had increased circulating T-follicular helper cells (cTfh), increased T-cell activation, and decreased naïve CD4+ T cells for age. Despite normal or high immunoglobulin G (IgG) in most pES at presentation, class-switched memory B cells were decreased. Within the cTfh subset, we noted features of postactivation exhaustion with upregulation of several canonical checkpoint inhibitors. T-cell receptor ß chain (TCR-ß) repertoire analysis of cTfh cells revealed increased oligoclonality in patients with pES compared with HCs. Among patients with pES, those without a known gene defect had a similar characteristic immune abnormality as patients with defined genetic defects. Similarly, patients with pES with normal IgG had similar T-cell abnormalities as patients with low IgG. Because genetic defects have been identified in less than half of patients with pES, our findings of similar immune abnormalities across all patients with pES help establish a common characteristic immunopathology in pES, irrespective of the underlying genetic etiology.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitopenia / Ativação Linfocitária / Linfócitos T Auxiliares-Indutores / Anemia Hemolítica Autoimune Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitopenia / Ativação Linfocitária / Linfócitos T Auxiliares-Indutores / Anemia Hemolítica Autoimune Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article